======= PRR14L ======= == Gene Information == * **Official Symbol**: PRR14L * **Official Name**: proline rich 14 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=253143|253143]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5THK1|Q5THK1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRR14L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRR14L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/621035|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A No Pfam Domain information is available for this gene. No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-3.17| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-3.12| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-3.08| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-2.39| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-2.18| |[[:results:exp150|SGC0649 7μM R03 exp150]]|-1.98| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-1.9| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-1.89| |[[:results:exp17|DABN 20μM R00 exp17]]|-1.81| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-1.78| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|1.74| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|1.79| |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|1.83| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.83| |[[:results:exp480|ETC-159 50μM R08 exp480]]|1.84| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|1.85| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|1.96| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|1.97| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|2.05| |[[:results:exp432|YM155 0.001μM R08 exp432]]|2.37| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|2.49| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.59| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|2.74| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|3.14| ^Gene^Correlation^ |[[:human genes:r:rbm38|RBM38]]|0.559| |[[:human genes:k:kdm6a|KDM6A]]|0.465| |[[:human genes:a:anp32a|ANP32A]]|0.421| |[[:human genes:d:dazap1|DAZAP1]]|0.412| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15339 * **Expression level (log2 read counts)**: 6.89 {{:chemogenomics:nalm6 dist.png?nolink |}}